Targeting signal transduction as a strategy to treat inflammatory diseases. (Q36506311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Targeting signal transduction as a strategy to treat inflammatory diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1

Luke A J O'Neill

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

14 August 2017

9 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

549-563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16773072%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd2070

29 January 2020

exact match

0 references

cites work

New drugs for rheumatoid arthritis

1 reference

Cardiovascular hazard and non-steroidal anti-inflammatory drugs

31 March 2020

1 reference

Does safety make a difference in selecting the right TNF antagonist?

31 March 2020

1 reference

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

31 March 2020

1 reference

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

31 March 2020

1 reference

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

31 March 2020

1 reference

The potential of PDE4 inhibitors in respiratory disease

31 March 2020

1 reference

Phosphodiesterase inhibitors in airways disease

31 March 2020

1 reference

Cyclic GMP phosphodiesterase-5: target of sildenafil

31 March 2020

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

31 March 2020

1 reference

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

31 March 2020

1 reference

TNF alpha--a pivotal role in rheumatoid arthritis?

31 March 2020

1 reference

Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants.

31 March 2020

1 reference

Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.

31 March 2020

1 reference

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

31 March 2020

1 reference

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

31 March 2020

1 reference

How Toll-like receptors signal: what we know and what we don't know

31 March 2020

1 reference

NLRs join TLRs as innate sensors of pathogens

31 March 2020

1 reference

Interleukin-17 family members and inflammation

31 March 2020

1 reference

Control of lymphocyte development by nuclear factor-kappaB.

31 March 2020

1 reference

31 March 2020

The NF-kappaB pathway

1 reference

Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers

31 March 2020

1 reference

The IKK NF-kappa B system: a treasure trove for drug development

31 March 2020

1 reference

Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.

31 March 2020

1 reference

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

31 March 2020

1 reference

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

31 March 2020

1 reference

Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.

31 March 2020

1 reference

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

31 March 2020

1 reference

Transcriptional and post-transcriptional control of gene expression in inflammation

31 March 2020

1 reference

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo

31 March 2020

1 reference

The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.

31 March 2020

1 reference

Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development

31 March 2020

1 reference

Targeting JNK for therapeutic benefit: from junk to gold?

31 March 2020

1 reference

Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1

31 March 2020

1 reference

Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.

31 March 2020

1 reference

A new modality for immunosuppression: targeting the JAK/STAT pathway

31 March 2020

1 reference

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

31 March 2020

1 reference

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

31 March 2020

1 reference

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.

31 March 2020

1 reference

Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

31 March 2020

1 reference

mTOR--beyond transplantation

31 March 2020

1 reference

Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway

31 March 2020

1 reference

Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases

31 March 2020

1 reference

Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place

31 March 2020

1 reference

Inhibitors of the mammalian target of rapamycin

31 March 2020

1 reference

Interleukin-17 family and IL-17 receptors

31 March 2020

1 reference

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway

31 March 2020

1 reference

Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members

31 March 2020

1 reference

The Toll-IL-1 receptor adaptor family grows to five members.

31 March 2020

1 reference

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

31 March 2020

1 reference

Triggering the interferon antiviral response through an IKK-related pathway

31 March 2020

1 reference

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

31 March 2020

1 reference

Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response

31 March 2020

1 reference

Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

31 March 2020

1 reference

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction

31 March 2020

1 reference

Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium

31 March 2020

1 reference

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

31 March 2020

1 reference

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

31 March 2020

1 reference

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

31 March 2020

1 reference

The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense

31 March 2020

1 reference

Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation.

31 March 2020

1 reference

RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.

31 March 2020

1 reference

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

31 March 2020

1 reference

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

31 March 2020

1 reference

Signalling pathways and molecular interactions of NOD1 and NOD2

31 March 2020

1 reference

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

31 March 2020

1 reference

Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing

31 March 2020

1 reference

Cryopyrin activates the inflammasome in response to toxins and ATP

31 March 2020

1 reference

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

31 March 2020

1 reference

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

31 March 2020

1 reference

Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation

31 March 2020

1 reference

Gout-associated uric acid crystals activate the NALP3 inflammasome

31 March 2020

1 reference

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

31 March 2020

1 reference

Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa.

31 March 2020

1 reference

Ciclesonide: a novel inhaled corticosteroid

31 March 2020

1 reference

Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma

31 March 2020

1 reference

PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.

31 March 2020

1 reference

New advances and potential therapies for the treatment of asthma

31 March 2020

1 reference